» Authors » Chuanqiang Niu

Chuanqiang Niu

Explore the profile of Chuanqiang Niu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 21
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang H, Guo Y, Tan X, Jiang Y, Pang N, Niu C, et al.
Colloids Surf B Biointerfaces . 2024 Aug; 244:114174. PMID: 39197327
Hemangiomas are superficial tumors characterized by dense vascular structures that often affect the patient's aesthetic appearance due to the obvious red appearance on the skin. Current treatments, especially timolol maleate...
2.
3.
Jiang H, Niu C, Guo Y, Liu Z, Jiang Y
Int Immunopharmacol . 2022 Jul; 111:108855. PMID: 35905560
Retinoblastoma is a most frequently occurring primary intraocular tumor in infancy and children, highlighting the requirement to find and develop novel and more effective therapeutic approaches. Wedelolactone (WDL), a nature...
4.
Jiang H, Shen G, Xu W, Niu C, Liu Z, Xia J, et al.
J Interv Med . 2021 Nov; 1(2):98-101. PMID: 34805837
The present study determined the efficacy and toxicity of second-course intra-arterial chemotherapy (IAC) in advanced retinoblastoma (RB) recurrence in children following failed initial IAC. A total of 24 child patients...
5.
Zhang J, Xu F, Chen K, Zhou S, Li H, Niu C, et al.
Oncol Lett . 2013 Oct; 6(3):850-854. PMID: 24137424
The objective of the present study was to investigate the feasibility and efficacy of pre-operative transcatheter arterial chemoembolization (TACE) for unresectable hepatoblastoma in infants and children. A total of 24...
6.
Niu C, Sun Q, Zhou J, Cheng D, Hong G
Asian Pac J Cancer Prev . 2012 Feb; 12(8):1995-9. PMID: 22292640
Targeted delivery of anti-cancer drugs is a highly desirable strategy to improve therapeutic outcome because of the combination of enhanced efficacy and reduced toxicity. In this study, the anti-cancer drug...